These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8161010)

  • 21. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of modified diagnostic ultrasound and microbubbles to reduce myocardial infarct size.
    Wu J; Xie F; Lof J; Sayyed S; Porter TR
    Heart; 2015 Sep; 101(18):1468-74. PubMed ID: 26109588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thrombolytic treatment in acute myocardial infarction. Choice of preparations in Norwegian hospitals].
    Andreassen AK; Gullestad L; Endresen K
    Tidsskr Nor Laegeforen; 1998 Jun; 118(17):2630-1. PubMed ID: 9673511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A randomized clinical trial on comparison of weight-adjusted dose with low dose recombinant tissue-type plasminogen activator on Chinese patients with acute myocardial infarction].
    Jiang SL; Zhang Y; Ji XP; Zhang L; Song ZF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1102-5. PubMed ID: 16563280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
    Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
    Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
    Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
    Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044
    [No Abstract]   [Full Text] [Related]  

  • 28. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does 'front-loading' with rt-PA improve treatment of acute myocardial infarction?
    Vine DL
    Kans Med; 1993 Apr; 94(4):116, 115. PubMed ID: 8487458
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.
    Van de Werf F; Barron HV; Armstrong PW; Granger CB; Berioli S; Barbash G; Pehrsson K; Verheugt FW; Meyer J; Betriu A; Califf RM; Li X; Fox NL;
    Eur Heart J; 2001 Dec; 22(24):2253-61. PubMed ID: 11728145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Increased efficacy of thrombolytic therapy in acute myocardial infarction by improved properties of new thrombolytic agents].
    Huber K
    Wien Klin Wochenschr; 2000 Sep; 112(17):742-8. PubMed ID: 11042902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.
    Naylor CD; Armstrong PW
    CMAJ; 1989 Jun; 140(11):1289-99. PubMed ID: 2497946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mutant t-PA compared with native t-PA in acute myocardial infarction].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():453-6. PubMed ID: 12735014
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction.
    Modi NB; Eppler S; Breed J; Cannon CP; Braunwald E; Love TW
    Thromb Haemost; 1998 Jan; 79(1):134-9. PubMed ID: 9459338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 40-year-old patient with an evolving extensive inferior MI treated with t-PA thrombolytic therapy.
    Denke NJ
    J Emerg Nurs; 1988; 14(6):334-7. PubMed ID: 3144621
    [No Abstract]   [Full Text] [Related]  

  • 37. t-PA therapy in acute myocardial infarction.
    Giebel RA; Pavey SS; Bryant PP
    J Emerg Nurs; 1988; 14(4):206-13. PubMed ID: 3137387
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombolytic therapy orders and record sheets: nursing care made easier.
    Rafter RH
    J Emerg Nurs; 1988; 14(4):237-9. PubMed ID: 3137388
    [No Abstract]   [Full Text] [Related]  

  • 39. Fatal Hemoptysis during Coronary Thrombolysis.
    Basher AW; Oduwole A; Bhalodkar NC; Mohideen B; Sy E; Sehonanda A; Brown Jr
    J Thromb Thrombolysis; 1996; 3(1):87-89. PubMed ID: 10608042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The fibrinolytic activity of menstrual blood.
    ALBRECHTSEN OK
    Acta Endocrinol (Copenh); 1956 Oct; 23(2):219-26. PubMed ID: 13372163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.